Constellium Se (CSTM) intrinsic value & 10-year financials
Constellium Se (CSTM) has a Graham intrinsic value of €30.45 per share. At €25.47 on Oct 17, 2026, the stock trades 16% below that value. Over the last 10 fiscal years revenue grew 6.6% a year to €8.4B, with an average return on invested capital of 10.9%.
- Graham intrinsic value
- €30.45
- Share price (Oct 17, 2026)
- €25.47
- Price vs Graham value
- 16% below
- Market cap
- €3.6B
- Revenue (FY2025)
- €8.4B
- Revenue growth (10-yr CAGR)
- 6.6%
- ROIC (10-yr avg)
- 10.9%
- Free cash flow (FY2025)
- €159.0M
CSTM 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | €8.4B | €273.0M | €1.92 | €159.0M | — | 10.4% |
| FY2024 | €7.3B | €56.0M | €0.38 | -€112.0M | — | 2.3% |
| FY2023 | €7.8B | €152.0M | €1.03 | €66.0M | 4.3% | 9.2% |
| FY2022 | €8.5B | €308.0M | €2.10 | €76.0M | 3.9% | 14.6% |
| FY2021 | €6.2B | €262.0M | €1.75 | €125.0M | 7.9% | 20.4% |
| FY2020 | €4.9B | -€17.0M | -€0.15 | €152.0M | 2.6% | 3.2% |
| FY2019 | €5.9B | €64.0M | €0.41 | €176.0M | 4.3% | 10.0% |
| FY2018 | €5.7B | €190.0M | €1.37 | -€211.0M | 7.1% | 20.3% |
| FY2017 | €5.2B | -€31.0M | -€0.28 | -€116.0M | 6.1% | 10.4% |
| FY2016 | €4.7B | -€4.0M | -€0.04 | -€267.0M | 5.2% | 7.9% |
Source: annual 10-K filings on SEC EDGAR. Figures in EUR.
Executive summary
CONSTELLIUM SE has demonstrated mature, steady growth, with revenue compounding at 6.6% annually over the past decade.
CONSTELLIUM SE returns on capital have been average, hovering around 10.9% ROIC over the decade.
CONSTELLIUM SE has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, CONSTELLIUM SE is modeled at 4.9% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $30.45 per share.